Skip to main content
# Title Department Research Member Research Year
571 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
572 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2018
573 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Department of Radiotherapy and Nuclear medicine Prof. Hamza Abbas Hamza Mohammed 2018
574 Nutritional Assessment and Intervention Methods in Children at Pediatric Oncology Department Department of Pediatric Oncology Mohammed Zakrya Ahmed Saleh 2018
575 Efficacy of Postoperative Analgesia of Local Ketamine
Wound Instillation Following Total Thyroidectomy
A Randomized, Double-blind, Controlled Clinical Trial
Department of Anesthesia, Intensive care and Pain management Dr. Doaa Jumaa Ahmad Syed 2018
576 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2018
577 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018
578 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Prof. Ashraf Amin Mohamed 2018
579 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2018
580 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018